Pharmaceuticals
Study links PAM gene variants to weaker blood-sugar response to GLP-1 drugs such as Ozempic
Reported by AI Image generated by AI Fact checked
Researchers say genetic variants in the PAM gene may help explain why some people with Type 2 diabetes get less blood-sugar benefit from GLP-1 receptor agonist drugs such as Ozempic, a phenomenon they describe as “GLP-1 resistance.”
Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.
Reported by AI
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents has named Sharif Ahmed El Akhdar non-executive chairman following LVP Pharma’s investment. Two additional board members joined at the same time.
Egyptian Health Minister Khaled Abdel Ghaffar urged stronger local pharmaceutical manufacturing to build resilient healthcare supply chains.
Reported by AI
Gland Pharma shares reached a new 52-week high after the company reported strong results for the March quarter and full year. The European unit Cenexi showed signs of recovery while new product launches and capacity additions supported the outlook.
A Japanese health panel has approved national health insurance coverage for Sumitomo Pharma's Amchepry, an iPS cell-derived treatment for Parkinson’s disease. The move makes it the world's first commercialized medical product from iPS cells.
Reported by AI
Dr Reddy's Laboratories expects a gradual recovery in the current fiscal year after a profit decline last year. Growth in India, Europe, and emerging markets is offsetting pressures in the US business. New product launches and margin improvements are set to support expansion.
Egypt and Mauritania explore expanded healthcare cooperation
June 02, 2026 20:02Osaka police refer three to prosecutors over Mounjaro sales
June 01, 2026 19:44Bioinvent hosts kol event on ovarian cancer therapies
June 01, 2026 12:23Wockhardt gains usfda approval for zaynich antibiotic
May 29, 2026 23:17FDA approves Afrezza for pediatric diabetes patients
May 17, 2026 09:14Alfresa Holdings Corporation releases 2026 Q4 earnings presentation
May 16, 2026 03:12Egypt explores pharma and healthcare investment with US firm
May 15, 2026 02:19ARS Pharmaceuticals reports strong start to 2026 in earnings call
May 14, 2026 15:48Arrowhead pharmaceuticals ceo stresses dual r&d and commercial focus
May 14, 2026 00:38Inovio Pharmaceuticals reviews Q1 results and INO-3107 FDA status